BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 15 filers reported holding BIOMX INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,035 | -53.1% | 150,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,205 | -34.1% | 150,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,345 | -44.2% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 150,000 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -77.3% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $22,000 | +46.7% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,000 | -68.1% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $47,000 | -48.9% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $92,000 | -11.5% | 150,000 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $104,000 | -12.6% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $119,000 | +14.4% | 150,000 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $104,000 | +44.4% | 150,000 | 0.0% | 0.01% | +75.0% |
| Q2 2020 | $72,000 | -26.5% | 150,000 | 0.0% | 0.00% | -66.7% |
| Q1 2020 | $98,000 | +27.3% | 150,000 | 0.0% | 0.01% | +100.0% |
| Q4 2019 | $77,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |